In vivo modeling of prodromal stage of Parkinson's disease

被引:5
|
作者
Cerri, Silvia [1 ]
Blandini, Fabio [1 ,2 ]
机构
[1] IRCCS Mondino Fdn, Lab Cellular & Mol Neurobiol, Via Mondino 2, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy
关键词
Parkinson's disease; Animal models; Prodromal; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; DOPAMINERGIC-NEURONS; NIGROSTRIATAL NEURODEGENERATION; ALPHA-SYNUCLEINOPATHY; ANIMAL-MODELS; MOUSE MODEL; RAT MODEL; MICE; IMPAIRMENTS; MODULATION;
D O I
10.1016/j.jneumeth.2020.108801
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) has a long prodromal period that precedes the appearance of typical motor symptoms. This phase is extremely heterogeneous and is characterized by a wide range of non-motor alterations including REM sleep behavior disorders, constipation, olfactory and urinary dysfunctions. The increasing clinical and experimental knowledge on prodromal PD has led to the development of novel animal models recapitulating this disease stage as well as to a new use and interpretation of existing models. Prodromal animal models of PD represent an important tool for testing new therapeutic strategies and shedding light on the early pathogenic steps that set the ground for the extensive dopaminergic cell death observed in the midbrain. This review summarizes the new insights that these models have provided into the comprehension of a complex and still unexplored stage of PD.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Heterogeneity in progression of prodromal features in Parkinson's disease
    Schrag, A.
    Zhelev, S. S.
    Hotham, S.
    Merritt, R. D.
    Khan, K.
    Graham, L.
    PARKINSONISM & RELATED DISORDERS, 2019, 64 : 275 - 279
  • [42] Plasma Glutathione and Prodromal Parkinson's Disease Probability
    Charisis, Sokratis
    Ntanasi, Eva
    Stamelou, Maria
    Xiromerisiou, Georgia
    Maraki, Maria
    Veskoukis, Aristidis S.
    Yannakoulia, Mary
    Kosmidis, Mary H.
    Anastasiou, Costas A.
    Giagkou, Nikolaos
    Dardiotis, Efthimios
    Hadjigeorgiou, Georgios
    Sakka, Paraskevi
    Kouretas, Demetrios
    Stefanis, Leonidas
    Scarmeas, Nikolaos
    MOVEMENT DISORDERS, 2022, 37 (01) : 200 - 205
  • [43] Experimental Animal Models of Prodromal Parkinson's Disease
    Yamakado, Hodaka
    Takahashi, Ryosuke
    JOURNAL OF PARKINSONS DISEASE, 2024, 14 : S369 - S379
  • [44] Ultrasonography Markers in Prodromal Parkinson's disease (PD)
    Secades Garcia, S.
    Perez, J.
    La Casa, B.
    Contreras, A.
    Grandas, F.
    MOVEMENT DISORDERS, 2024, 39 : S484 - S484
  • [45] Motor signs in the prodromal phase of Parkinson's disease
    Maetzler, Walter
    Hausdorff, Jeffrey M.
    MOVEMENT DISORDERS, 2012, 27 (05) : 627 - 633
  • [46] Prodromal Parkinson's disease (PD) in the General Population
    de Klerk, G.
    van Laar, T.
    Meles, S.
    MOVEMENT DISORDERS, 2024, 39 : S163 - S163
  • [47] The significance of defining preclinical or prodromal Parkinson's disease
    Olanow, C. Warren
    Obeso, Jose A.
    MOVEMENT DISORDERS, 2012, 27 (05) : 666 - 669
  • [48] Cognitive complaint as a prodromal symptom in Parkinson's disease?
    Gerton, B. K.
    Tsuang, D. W.
    Peskind, E. R.
    Montine, T. J.
    Leverenz, J. B.
    MOVEMENT DISORDERS, 2009, 24 : S298 - S299
  • [49] Hemifacial spasm as prodromal manifestation of Parkinson's disease
    Leonardos, A
    Potagas, C
    Vassilopoulos, D
    JOURNAL OF NEUROLOGY, 2005, 252 : 144 - 144
  • [50] Cognitive Changes in Prodromal Parkinson's Disease: A Review
    Fengler, Sophie
    Liepelt-Scarfone, Inga
    Brockmann, Kathrin
    Schaeffer, Eva
    Berg, Daniela
    Kalbe, Elke
    MOVEMENT DISORDERS, 2017, 32 (12) : 1655 - 1666